Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antioxidant metalloenzymes represent a vital class of enzymes that utilize metal ion cofactors to neutralize reactive oxygen species (ROS) and maintain cellular redox balance. This group primarily includes superoxide dismutases (SODs), which employ copper, zinc, manganese, or iron to disproportionate superoxide radicals; catalase, a heme-iron enzyme that decomposes hydrogen peroxide; and glutathione peroxidases (GPxs), which typically utilize selenium to reduce peroxides [PMID: 29470472, PMID: 22229314]. These enzymes serve as the primary defense mechanism against oxidative stress, which is a major driver of cellular damage to DNA, proteins, and lipids. Pathological depletion or dysfunction of these enzymes is associated with a wide range of conditions, including neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS), cardiovascular diseases, and chronic inflammation [PMID: 25470114, PMID: 28853752]. Pharmacological interventions targeting this system include the development of small-molecule mimetics, such as ebselen and mangafodipir, which aim to replicate the catalytic activity of the endogenous enzymes [PMID: 22536924]. However, therapeutic application is challenging due to the need for precise control over ROS levels, as complete suppression can interfere with essential redox signaling pathways.
Catalytic neutralization of reactive oxygen species (e.g., superoxide to hydrogen peroxide, hydrogen peroxide to water and oxygen) to prevent oxidative damage to cellular components [PMID: 29470472].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antioxidant metalloenzymes.